Novotech Global Report: Robust Phase 1 Trial Growth Across Asia Pacific
SYDNEY, AU, Feb 10, 2023 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific centred biotech CRO, has published a new global report on Phase 1 trial activity including current metrics on fast growth regions and therapeutic areas. The data analysis found that Asia PaciContinue Reading